SRD5A2 and prostate carcinoma: In human prostate cancer cells (DU-145) and HFDPC cells, the SFE-4 extract significantly decreased the expression of <i>SRD5A1</i>, <i>SRD5A2</i>, and <i>SRD5A3</i>, an essential pathway involved in AGA.